Table 1 Characteristics of Patients Study Cohort
Acute Phase (n = 63) | Chronic Phase (n = 43) | |
|---|---|---|
Age | 56 ± 7 | 55 ± 8 |
Male sex, n (%) | 56 (89) | 38 (88) |
Body mass index (kg/m2) | 25.5 ± 2.5 | 25.7 ± 2.6 |
Cardiovascular risk factors, n (%) | ||
Hypertension | 31 (49) | 22 (51) |
Diabetes | 12 (19) | 6 (14) |
Hyperlipidemia | 27 (43) | 19 (44) |
Smoking | 40 (63) | 29 (67) |
Heart rate (bpm) | 74 ± 14 | 70 ± 12 |
Infarct-related artery, n (%) | ||
Left anterior descending | 38 (60) | 27 (63) |
Left circumflex | 7 (11) | 5 (12) |
Right coronary artery | 18 (29) | 11 (25) |
Cardiovascular magnetic resonance findings | ||
LV ejection fraction (%) | 43.8 ± 7.2 | 46.0 ± 6.9 |
LV end-diastolic volume index (ml/m2) | 87.8 ± 17.7 | 89.0 ± 16.2 |
LV end-systolic volume index (ml/m2) | 50.5 ± 14.6 | 48.7 ± 13.2 |
Infarct volume (%LV) | 33.3 ± 12.4 | 22.7 ± 8.6 |
Late MVO volume (%LV) | 6.5 ± 6.0 | – |
Medication during admission, n (%) | ||
Antiplatelet therapy | 63 (100%) | |
Beta blocker | 59 (94%) | |
ACEI | 53 (84%) | |
ARB | 16 (25%) | |
CCB | 5 (8%) | |
Diuretic | 24 (38%) | |
Statin | 63 (100%) | |
Amiodarone | 7 (11%) | |
Nitrate | 56 (89%) | |